XORTX Therapeutics Inc.

US$0.91As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XRTXHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (42.69%)
Div yield —
ROE (99.24%)
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM (69.79%)
Mkt cap US$1.653M
ROIC (34.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.984
8.11%
(55.97%)
Hold 4|0|2|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.02
0.02
22.18%
21.14%
17.86%
15.62%
Revenue$M
0.187
0.188
0.185
0.183
4.96%
0.27%
(3.08%)
(3.12%)
Peers (US$1.653M)
Cap (US$)
PE
2.312M
—
Capital
TTM
5Y
10Y
Leveragex
1.474
—
—
EBIT/Intx
0.996
0.536
0.377
Own earn%
9.01
205.44
168.66
Sh yield%
22.71
12.50
16.68
Owners
Insiders/Inst%
1.92
89.63
Short interest%
4.40
SBC / revenue%
3.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
8–13
$1 testx
−0.8
Incr. ROIC%
15